July 11 (Reuters) - Intelgenx Technologies Corp IGX.V :
* Intelgenx announces notice of appeal for
buprenorphine/naloxone sublingual film product for the treatment
of opiate addiction
* Court ruled par's anda product would infringe asserted
claims of u.s. Patent no. 8,603,514
* Court rule one of orange book listed patents for suboxone
film, claims of u.s. Patent no. 8,603,514 were not shown to be
invalid
Source text for Eikon:
Further company coverage: IGX.V
(Bengaluru Newsroom: +1-646-223-8780)